Healthcare Services

Acute Coronary Syndrome Market Forecast Analysis Through 2030 With Insights On Industry Expansion

May 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Increase In Market Value Is Predicted For The Acute Coronary Syndrome Market During The 2026–2030 Period?

The acute coronary syndrome market size has experienced robust expansion in recent years. It is projected to increase from $10.43 billion in 2025 to $11.06 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.0%. Historically, this growth can be attributed to several factors including the rising prevalence of cardiovascular diseases, limited awareness of early ACS symptoms, the expansion of hospital cardiac facilities, the availability of conventional medications, and a growing geriatric population.

The acute coronary syndrome market size is poised for robust growth in the coming years. It is projected to expand to $14.51 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.0%. The expansion during the forecast period stems from the development of new anticoagulants and statins, a growing embrace of minimally invasive cardiac procedures, the increase in specialty clinics, heightened government initiatives aimed at preventing heart disease, and technological improvements in both imaging and stress testing. Significant trends expected throughout the forecast period involve a rising uptake of early diagnostic methods for ACS, expanded use of percutaneous coronary intervention (PCI), increased public knowledge regarding ACS risk factors and prevention, the enlargement of hospital cardiac care units, and progress in both oral and parenteral ACS treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12985&type=smp

Which Growth Factors Are Strengthening The Acute Coronary Syndrome Market Landscape?

Rising healthcare expenditures are expected to stimulate expansion in the acute coronary syndrome market. These expenditures denote the total funds spent on health-related services, products, and activities within a specific timeframe, typically at an individual, community, national, or global scale. Growth in healthcare spending is fueled by factors such as the increasing incidence of chronic diseases, an aging population, advancements in medical technology, and a heightened demand for more sophisticated treatments and health services. Such increased spending fosters development within the coronary syndrome sector by facilitating improved diagnostic tools, advanced therapeutic options, and comprehensive treatment solutions, thereby addressing the growing need for cardiovascular care. For instance, in May 2023, the Office for National Statistics, a UK-based statistical authority, reported that healthcare expenditure in the UK for 2023 was approximately $362.08 billion (£292 billion), representing a nominal increase of 5.6%. Additionally, long-term health and social care spending increased by 2.8% in real terms in 2022. Therefore, continued growth in healthcare expenditure will propel the acute coronary syndrome market’s growth moving forward.

How Is The Acute Coronary Syndrome Market Examined Through Segment Analysis?

The acute coronary syndrome market covered in this report is segmented –

1) By Type: Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina

2) By Treatment: Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment

3) By Diagnosis: Stress Test, Blood Tests, Imaging, Other Diagnosis

4) By Route Of Administration: Oral, Parenteral

5) By End-User: Hospitals, Specialty clinics, Other End User

Subsegments:

1) By Non-ST-Elevation Myocardial Infarction: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)

2) By ST-Elevation Myocardial Infarction: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)

3) By Unstable Angina: Medical Management, Percutaneous Coronary Intervention (PCI), Coronary Artery Bypass Grafting (CABG)

Which Trends Are Affecting The Acute Coronary Syndrome Market Framework?

Key companies operating within the acute coronary syndrome market are actively developing innovative pharmaceuticals to address acute coronary syndrome and maintain their market standing. Such advancements in drug creation have the potential to boost the efficiency of ACS treatment, subsequently decreasing the time and resources required per patient. For instance, in June 2023, AGEPHA Pharma USA LLC, a US-based pharmaceutical firm, introduced Lodoco, which received approval from the Food and Drug Administration (FDA), a US-based government agency. This product is the first anti-inflammatory atheroprotective cardiovascular treatment that works to reduce the risk of heart stroke, coronary revascularization, myocardial infarction (MI), and cardiovascular death in adult patients diagnosed with cardiovascular diseases, including acute coronary syndrome.

Who Are The Businesses Driving Activity In The Acute Coronary Syndrome Market?

Major companies operating in the acute coronary syndrome market are Pfizer Inc., Johnson and Johnson Limited, Siemens AG, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Medtronic Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Stryker Corporation, GE Healthcare Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Daiichi Sankyo Company Limited, Terumo Corp., BioMérieux SA, Beckman Coulter Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Biotronik Inc., Randox Laboratories Limited, Nihon Kohden Corporation, Trinity Biotech plc

Access The Complete Acute Coronary Syndrome Market Report:

https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

What Is The Largest Regional Market In The Acute Coronary Syndrome Market?

North America was the largest region in the acute coronary syndrome market in 2025. The regions covered in the acute coronary syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Acute Coronary Syndrome Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12985&type=smp

Browse Through More Reports Similar to the Global Acute Coronary Syndrome Market 2026, By The Business Research Company

Coronary Artery Disease Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Myocardial Infarction Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/myocardial-infarction-global-market-report

Coronary Stents Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795